LACUTLASS BYNO: Open Payments
NPI 1952032393 · BYHALIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$313 in 6 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $321 · 2025 $313
Food & beverage: $313
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $171 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $107 |
| Collegium Pharmaceutical, Inc. | 1 | $18 |
| ABBVIE INC. | 1 | $17 |
Products named: JARDIANCE, Ozempic, Wegovy, Jornay PM, VRAYLAR.
Industry payments across MS — which companies pay providers there.
